Phase II/III of Randomized Controlled Clinical Research on IRE Synchronous Chemotherapy for LAPC

NCT03673137 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Locally Advanced Pancreatic Adenocarcinoma

Interventions

DEVICE: Irreversible electroporation
DRUG: Gemcitabine

Sponsor

Fuda Cancer Hospital, Guangzhou